5C57.0

ICD-11 MMS 2026-01

Disorders of peroxisome biogenesis

Description

Peroxisome biogenesis disorders (PBDs) include the Zellweger syndrome spectrum (PBD-ZSD) and rhizomelic chondrodysplasia punctata type 1 (RCDP1). PBD-ZSD represents a continuum of disorders including infantile Refsum disease, neonatal adrenoleukodystrophy, and Zellweger syndrome. Collectively, PBDs are autosomal recessive developmental brain disorders that also result in skeletal and craniofacial dysmorphism, liver dysfunction, progressive sensorineural hearing loss, and retinopathy.

Index terms

  • Disorders of peroxisome biogenesis
  • Hyperpipecolic acidaemia
  • Zellweger spectrum disorder
Show allHide
  • Zellweger syndrome
  • Cerebrohepatorenal syndrome
  • Zellweger spectrum disorder, severe form
  • Zellweger spectrum disorder, mild form
  • Zellweger spectrum disorder, unclassified clinical severity
  • PEX1 deficiency
  • PEX2 deficiency
  • PEX3 deficiency
  • PEX5 deficiency
  • PEX6 deficiency
  • PEX10 deficiency
  • PEX12 deficiency
  • PEX13 deficiency
  • PEX14 deficiency
  • PEX16 deficiency
  • PEX19 deficiency
  • PEX26 deficiency

Exclusions from above levels

  • http://id.who.int/icd/entity/1191191920 – Disorders of lipoprotein metabolism or certain specified lipidaemias
  • 3A10.Z – Hereditary haemolytic anaemia due to enzyme deficiency
  • 5A71.01 – Congenital adrenal hyperplasia
Show allHide
  • 5A81.1 – 5-alpha-reductase deficiency
  • LD28.01 – Marfan syndrome
  • LD28.1 – Ehlers-Danlos syndrome
  • LD2A.4 – androgen resistance syndrome
  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Sibling codes

  • 5C57.1 – Disorders of peroxisomal alpha-, beta- or omega-oxidation
  • 5C57.Y – Other specified peroxisomal diseases
  • 5C57.Z – Peroxisomal diseases, unspecified

Foundation entity

Disorders of peroxisome biogenesis – http://id.who.int/icd/entity/1919322367

Part of: 5C57: Peroxisomal diseases › 05: Endocrine, nutritional or metabolic diseases